• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在线提供健康信息:基于搜索引擎驱动的系统性网络分析

Online Provision of and Health Information: A Search Engine Driven Systematic Web-Based Analysis.

作者信息

Gootzen Tamar A, Kalra Ashwin, Sarig Katrina, Sobočan Monika, Oxley Samuel George, Dworschak Nina, Georgiannakis Ariadni, Glynou Sevasti, Taniskidi Angeliki, Ganesan Subhasheenee, Ferris Michelle, Legood Rosa, Eeles Ros, Evans D Gareth R, Fierheller Caitlin T, Manchanda Ranjit

机构信息

Centre for Cancer Screening, Prevention & Early Diagnosis, Wolfson Institute of Population Health, Charterhouse Square, Queen Mary University of London, London EC1M 6BQ, UK.

Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.

出版信息

Cancers (Basel). 2024 Jun 25;16(13):2324. doi: 10.3390/cancers16132324.

DOI:10.3390/cancers16132324
PMID:39001386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11240379/
Abstract

genetic testing is available for UK Jewish individuals but the provision of information online for is unknown. We aimed to evaluate online provision of information by UK organisations (UKO), UK Jewish community organisations (JCO), and genetic testing providers (GTP). Google searches for organisations offering information were performed using relevant sets of keywords. The first 100 website links were categorised into UKOs/JCOs/GTPs; additional JCOs were supplemented through community experts. Websites were reviewed using customised questionnaires for information. Information provision was assessed for five domains: accessibility, scope, depth, accuracy, and quality. These domains were combined to provide a composite score (maximum score = 5). Results were screened ( = 6856) and 45 UKOs, 16 JCOs, and 18 GTPs provided information. Accessibility was high (84%,66/79). Scope was lacking with 35% (28/79) addressing >50% items. Most (82%, 65/79) described -associated cancers: breast and/or ovarian cancer was mentioned by 78%(62/79), but only 34% (27/79) mentioned ≥1 pancreatic, prostate, melanoma. Few websites provided carrier frequencies in the general (24%,19/79) and Jewish populations (20%,16/79). Only 15% (12/79) had quality information with some/minimal shortcomings. Overall information provision was low-to-moderate: median scores UKO = 2.1 (IQR = 1), JCO = 1.6 (IQR = 0.9), and GTP = 2.3 (IQR = 1) (maximum-score = 5). There is a scarcity of high-quality information online. These findings have implications for UK Jewish programmes and those considering testing.

摘要

基因检测服务面向英国犹太人群体,但在线信息提供情况不明。我们旨在评估英国组织(UKO)、英国犹太社区组织(JCO)和基因检测供应商(GTP)在线提供的信息。使用相关关键词集在谷歌上搜索提供信息的组织。前100个网站链接被归类为UKO/JCO/GTP;通过社区专家补充了其他JCO。使用针对信息的定制问卷对网站进行审查。从可及性、范围、深度、准确性和质量五个领域评估信息提供情况。这些领域合并得出综合评分(最高分 = 5)。筛选结果(= 6856),45个UKO、16个JCO和18个GTP提供了信息。可及性较高(84%,66/79)。范围不足,35%(28/79)涉及超过50%的项目。大多数(82%,65/79)描述了相关癌症:78%(62/79)提到了乳腺癌和/或卵巢癌,但只有34%(27/79)提到了≥1种胰腺癌、前列腺癌、黑色素瘤。很少有网站提供一般人群(24%,19/79)和犹太人群体(20%,16/79)的携带者频率。只有15%(12/79)有质量信息且存在一些/极小的缺陷。总体信息提供水平为低到中等:UKO的中位数评分 = 2.1(四分位距 = 1),JCO = 1.6(四分位距 = 0.9),GTP = 2.3(四分位距 = 1)(最高分 = 5)。在线高质量信息匮乏。这些发现对英国犹太基因项目以及考虑基因检测的人具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/11240379/10d0cff1a55e/cancers-16-02324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/11240379/10d0cff1a55e/cancers-16-02324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/11240379/10d0cff1a55e/cancers-16-02324-g001.jpg

相似文献

1
Online Provision of and Health Information: A Search Engine Driven Systematic Web-Based Analysis.在线提供健康信息:基于搜索引擎驱动的系统性网络分析
Cancers (Basel). 2024 Jun 25;16(13):2324. doi: 10.3390/cancers16132324.
2
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.基于人群的 BRCA1 种系突变检测在 Sephardi 犹太女性中的成本效益。
Am J Obstet Gynecol. 2018 Apr;218(4):431.e1-431.e12. doi: 10.1016/j.ajog.2017.12.221. Epub 2017 Dec 26.
3
4
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.基于不同阿什肯纳兹犹太血统人群的BRCA检测的成本效益。
Am J Obstet Gynecol. 2017 Nov;217(5):578.e1-578.e12. doi: 10.1016/j.ajog.2017.06.038. Epub 2017 Jul 6.
5
awareness and testing experience in the UK Jewish population: a qualitative study.英国犹太人群体的艾滋病知晓率和检测经验:一项定性研究。
J Med Genet. 2024 Jun 20;61(7):716-725. doi: 10.1136/jmg-2023-109576.
6
Community attitudes towards a Jewish community BRCA1/2 testing program.社区对犹太社区BRCA1/2检测项目的态度。
Fam Cancer. 2017 Jan;16(1):17-28. doi: 10.1007/s10689-016-9918-0.
7
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.BRCA1 和 BRCA2 基因突变的犹太裔妇女进行人群遗传筛查的长期随访。
Breast Cancer Res Treat. 2012 Jun;133(2):735-40. doi: 10.1007/s10549-011-1941-0. Epub 2012 Jan 13.
8
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.基于人群的 BRCA 检测在阿什肯纳兹犹太人中的随机试验:长期结果。
BJOG. 2020 Feb;127(3):364-375. doi: 10.1111/1471-0528.15905. Epub 2019 Sep 10.
9
Evaluation of two population screening programmes for founder mutations in the Australian Jewish community: a protocol paper.评估澳大利亚犹太人群体中两种致病变异体的人群筛查计划:方案文件。
BMJ Open. 2021 Jun 25;11(6):e041186. doi: 10.1136/bmjopen-2020-041186.
10
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.在没有自我报告犹太血统的个体中识别阿什肯纳兹犹太人 BRCA1/2 种系变异。
Sci Rep. 2020 May 6;10(1):7669. doi: 10.1038/s41598-020-63466-x.

本文引用的文献

1
Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.卵巢癌:识别与管理家族性和遗传风险——英国国家卫生与临床优化研究所新指南摘要
BMJ. 2024 May 9;385:q807. doi: 10.1136/bmj.q807.
2
BRCA testing launched for people of Jewish ancestry in England.英国针对犹太裔人群开展BRCA检测。
Lancet Oncol. 2024 Mar;25(3):284. doi: 10.1016/S1470-2045(24)00087-1. Epub 2024 Feb 8.
3
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.卵巢癌和乳腺癌基因特异性预防策略的成本效益分析。
JAMA Netw Open. 2024 Feb 5;7(2):e2355324. doi: 10.1001/jamanetworkopen.2023.55324.
4
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.患者决策辅助工具在卵巢癌女性基因检测中的主流化:一项前瞻性队列研究。
BJOG. 2024 May;131(6):848-857. doi: 10.1111/1471-0528.17675. Epub 2023 Sep 26.
5
Cervical Cancer Prevention on Instagram: Content and Social Interaction Analysis of Brazilian Accounts.在 Instagram 上预防宫颈癌:巴西账户的内容和社交互动分析。
Asian Pac J Cancer Prev. 2022 Sep 1;23(9):3043-3049. doi: 10.31557/APJCP.2022.23.9.3043.
6
Population-based genetic testing for cancer susceptibility genes: quo vadis?基于人群的癌症易感基因检测:路在何方?
BJOG. 2023 Jan;130(2):125-130. doi: 10.1111/1471-0528.17283. Epub 2022 Sep 8.
7
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot.英国国民保健制度中癌症患者基因检测的数字通路:BRCA-DIRECT 随机研究内部试点。
J Med Genet. 2022 Dec;59(12):1179-1188. doi: 10.1136/jmg-2022-108655. Epub 2022 Jul 22.
8
Surgical management of BRCA-mutation carriers: A single institution experience.BRCA 突变携带者的外科治疗:单中心经验。
Eur J Surg Oncol. 2022 Aug;48(8):1706-1712. doi: 10.1016/j.ejso.2022.04.024. Epub 2022 Apr 30.
9
Quality and readability of online patient information on treatment for erectile dysfunction.关于勃起功能障碍治疗的在线患者信息的质量与可读性。
BJUI Compass. 2021 May 6;2(6):412-418. doi: 10.1002/bco2.87. eCollection 2021 Nov.
10
Cancer Risks Associated With and Pathogenic Variants.与 BRCA1/2 基因和致病变异相关的癌症风险。
J Clin Oncol. 2022 May 10;40(14):1529-1541. doi: 10.1200/JCO.21.02112. Epub 2022 Jan 25.